[Form 4] Accenture PLC Insider Trading Activity

Rhea-AI Filing Summary

Alan C. Jope, a director of Accenture plc (ACN), reported an acquisition of 1,978 Class A ordinary shares on 08/15/2025. The shares were received as a grant of Restricted Share Units (RSUs) under anti-dilution provisions tied to a cash dividend; the report shows a deemed price of $247.57 per share. Following the transaction, Mr. Jope beneficially owns 1,978 shares directly. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses a routine equity award adjustment rather than an open-market trade.

Positive

• Director increased direct ownership by 1,978 Class A ordinary shares via RSU grant, improving alignment with shareholders

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine RSU anti-dilution adjustment increased the director's direct holdings by 1,978 shares; procedural disclosure only.

This Form 4 documents a non-market acquisition of shares via RSU anti-dilution provisions tied to a dividend payment. Such adjustments preserve the economic value of prior equity awards when dividends are paid. The filing is standard governance practice and provides transparency on director ownership. No sale, new compensation plan, or change in control is evident from the form.

Securities Analyst

TL;DR: Director received 1,978 RSUs at an implied price of $247.57; impact on float and insider position is immaterial.

The disclosure shows an acquisition of 1,978 Class A ordinary shares via RSU anti-dilution on 08/15/2025 at an implied value of $247.57 per share. This is an equity compensation accounting adjustment rather than a purchase or sale on the open market. The change in beneficial ownership is modest relative to Accenture's market capitalization and does not indicate directional insider trading activity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jope Alan C.

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	08/15/2025		A		6(1)	A	$247.57	1,978	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Alan C. Jope	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Alan C. Jope report on Form 4 for ACN?

The Form 4 reports an acquisition of 1,978 Class A ordinary shares via Restricted Share Units on 08/15/2025.

Why were the RSUs granted to Alan C. Jope?

The RSUs were granted pursuant to the anti-dilution provisions of previously awarded RSUs to reflect Accenture's payment of a cash dividend.

What price is shown on the Form 4 for the reported shares?

The filing shows an implied price of $247.57 per share for the reported acquisition.

How many shares does Alan C. Jope beneficially own after the transaction?

The Form 4 states Mr. Jope beneficially owns 1,978 shares following the reported transaction.

When was the Form 4 filed or signed?

The signature by an attorney-in-fact is dated 08/18/2025 and the transaction date is 08/15/2025.